NIVEGU.KNOW BEFORE YOU FLY

THE WORLD OF AVIATION.
YOUR JOURNEY, EXPLAINED.

Search Plan my trip
NASDAQ / LIVE COMPANY INTELLIGENCE

ACADIA Pharmaceuticals Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERACAD
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ACAD COVERAGE

What’s moving ACADIA Pharmaceuticals Inc. now

Current reporting with the operating signal separated from the noise.

01
Acadia Pharmaceuticals Inc. Announces Allowance of U.S. Patent Application Covering Weight-Banded Dosing of Trofinetide

Acadia Pharmaceuticals Inc. Announces Allowance of U.S. Patent Application Covering Weight-Banded Dosing of Trofinetide

The story matters when it changes ACADIA Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
ACADIA Pharmaceuticals Inc. (ACAD) Discusses Top-Line Phase II Results From RADIANT Study of Remlifanserin in Alzheimer's Disease Psychosis Transcript

ACADIA Pharmaceuticals Inc. (ACAD) Discusses Top-Line Phase II Results From RADIANT Study of Remlifanserin in Alzheimer's Disease Psychosis Transcript

The story matters when it changes ACADIA Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
03
Yahoo! Finance Canada

ACADIA Pharmaceuticals Inc. (ACAD) Stock Forecasts

Investors are testing whether ACADIA Pharmaceuticals Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Why ACADIA Pharmaceuticals Inc. (ACAD) Skyrocketed on Friday

Why ACADIA Pharmaceuticals Inc. (ACAD) Skyrocketed on Friday

The story matters when it changes ACADIA Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ACAD filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-08-05 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-07 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-09-24 · Period 2026-09-24SEC ↗8-KMaterial company eventFiled 2026-09-11 · Period 2026-09-11SEC ↗8-KMaterial company eventFiled 2026-08-04 · Period 2026-08-04SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-24 · Period 2026-05-29SEC ↗4Official SEC filingFiled 2026-08-07 · Period 2026-08-05SEC ↗
EARNINGS / QUARTERLY TRACKER

ACADIA Pharmaceuticals Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.